Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
  1. 2020
  2. Udgivet

    MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

    Monk, B. J., Grisham, R. N., Banerjee, S., Kalbacher, E., Mirza, M. R., Romero, I., Vuylsteke, P., Coleman, R. L., Hilpert, F., Oza, A. M., Westermann, A., Oehler, M. K., Pignata, S., Aghajanian, C., Colombo, N., Drill, E., Cibula, D., Moore, K. N., Christy-Bittel, J., Del Campo, J. M., Berger, R., Marth, C., Sehouli, J., O'Malley, D. M., Churruca, C., Boyd, A. P., Kristensen, G., Clamp, A., Ray-Coquard, I. & Vergote, I., 10 nov. 2020, I: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 32, s. 3753-3762 10 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Udgivet

    Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial

    Mirza, M. R., Benigno, B., Dørum, A., Mahner, S., Bessette, P., Barceló, I. B., Berton-Rigaud, D., Ledermann, J. A., Rimel, B. J., Herrstedt, J., Lau, S., du Bois, A., Herráez, A. C., Kalbacher, E., Buscema, J., Lorusso, D., Vergote, I., Levy, T., Wang, P., de Jong, F. A., Gupta, D. & Matulonis, U. A., nov. 2020, I: Gynecologic Oncology. 159, 2, s. 442-448 7 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Udgivet

    Results of the interprofessional and interdisciplinary Berlin round table on patient-reported outcomes, quality of life, and treatment expectations of patients with gynecological cancer under maintenance treatment

    Armbrust, R., Alavi, S., Pirmorady, A., Chen, F., Colombo, N., Gultekin, M., Hierro, C., Lemley, B., Mirza, M. R., Urkmez, E., Fotopoulou, C., Vinzent, J., Gonzalez Martin, A., Krull, A., Heepe, J., Rose, M. & Sehouli, J., okt. 2020, I: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 30, 10, s. 1603-1607 5 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Udgivet

    The forefront of ovarian cancer therapy: update on PARP inhibitors

    Mirza, M. R., Coleman, R. L., González-Martín, A., Moore, K. N., Colombo, N., Ray-Coquard, I. & Pignata, S., sep. 2020, I: Annals of Oncology. 31, 9, s. 1148-1159 12 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  6. Udgivet

    Incorporating Parp-inhibitors in Primary and Recurrent Ovarian Cancer: A Meta-analysis of 12 phase II/III randomized controlled trials

    Ruscito, I., Bellati, F., Ray-Coquard, I., Mirza, M. R., du Bois, A., Gasparri, M. L., Costanzi, F., De Marco, M. P., Nuti, M., Caserta, D., Pignata, S., Dorigo, O., Sehouli, J. & Braicu, E. I., jul. 2020, I: Cancer Treatment Reviews. 87, s. 102040 102040.

    Publikation: Bidrag til tidsskriftReviewpeer review

  7. Udgivet

    European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and industry partners - a new Model D for drug and medical device development

    Concin, N., Ray-Coquard, I., Glasspool, R. M., Braicu, E., Farrelly, L., Votan, B., Mirza, M. R., Gonzalez Martin, A., Vergote, I. & Pignata, S., jun. 2020, I: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 30, 6, s. 730-734 5 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  8. Udgivet

    Major clinical research advances in gynecologic cancer in 2019

    Kim, M., Suh, D. H., Lee, K. H., Eom, K. Y., Lee, J. Y., Lee, Y. Y., Hansen, H. F., Mirza, M. R. & Kim, J. W., maj 2020, I: Journal of Gynecologic Oncology. 31, 3, s. e48

    Publikation: Bidrag til tidsskriftReviewpeer review

  9. Udgivet

    Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies

    Vergote, I. B., Lund, B., Peen, U., Umajuridze, Z., Mau-Sorensen, M., Kranich, A., Van Nieuwenhuysen, E., Haslund, C., Nottrup, T., Han, S. N., Concin, N., Unger, T. J., Chai, Y., Au, N., Rashal, T., Joshi, A., Crochiere, M., Landesman, Y., Shah, J., Shacham, S., Kauffman, M. & Mirza, M. R., feb. 2020, I: Gynecologic Oncology. 156, 2, s. 308-314 7 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  10. Udgivet

    Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

    AGO Study Group-led GCIG/ENGOT Intergroup Consortium, 15 jan. 2020, I: International Journal of Cancer. 146, 2, s. 439-448 10 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  11. Udgivet

    Patterns of treatment failure in patients undergoing adjuvant or definitive radiotherapy for vulvar cancer

    Vorbeck, C. S., Jhingran, A., Iyer, R. B., Loft, A., Klopp, A., Mirza, M. R., Sobremonte, A., Vedam, S. & Vogelius, I. R., 2020, I: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 29, 5, s. 857-862 6 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  12. 2019
  13. Udgivet

    Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

    PRIMA/ENGOT-OV26/GOG-3012 Investigators, 19 dec. 2019, I: The New England journal of medicine. 381, 25, s. 2391-2402 12 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  14. Udgivet

    Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial

    Matulonis, U. A., Walder, L., Nøttrup, T. J., Bessette, P., Mahner, S., Gil-Martin, M., Kalbacher, E., Ledermann, J. A., Wenham, R. M., Woie, K., Lau, S., Marmé, F., Casado Herraez, A., Hardy-Bessard, A-C., Banerjee, S., Lindahl, G., Benigno, B., Buscema, J., Travers, K., Guy, H. & Mirza, M. R., 1 dec. 2019, I: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 34, s. 3183-3191 9 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  15. Udgivet

    Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial

    Del Campo, J. M., Matulonis, U. A., Malander, S., Provencher, D., Mahner, S., Follana, P., Waters, J., Berek, J. S., Woie, K., Oza, A. M., Canzler, U., Gil-Martin, M., Lesoin, A., Monk, B. J., Lund, B., Gilbert, L., Wenham, R. M., Benigno, B., Arora, S., Hazard, S. J. & Mirza, M. R., 10 nov. 2019, I: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 32, s. 2968-2973 6 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  16. Udgivet

    Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer

    Vergote, I., du Bois, A., Floquet, A., Rau, J., Kim, J-W., Del Campo, J. M., Friedlander, M., Pignata, S., Fujiwara, K., Colombo, N., Mirza, M. R., Monk, B. J., Tsibulak, I., Calvert, P. M., Herzog, T. J., Hanker, L. C., Meunier, J., Lee, J-Y., Bologna, A., Carrasco-Alfonso, M. J. & Harter, P., nov. 2019, I: Gynecologic Oncology. 155, 2, s. 186-191 6 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  17. Udgivet

    A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24

    Mirza, M. R., Bergmann, T. K., Mau-Sørensen, M., Christensen, R. D., Åvall-Lundqvist, E., Birrer, M. J., Jørgensen, M., Roed, H., Malander, S., Nielsen, F., Lassen, U., Brøsen, K., Bjørge, L. & Mäenpää, J., okt. 2019, I: Cancer Chemotherapy and Pharmacology. 84, 4, s. 791-798 8 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  18. Udgivet

    Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

    AVANOVA investigators, okt. 2019, I: Lancet Oncology. 20, 10, s. 1409-1419 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  19. Udgivet

    The DNA Repair Pathway as a Target for Novel Drugs in Gynecologic Cancers

    Lheureux, S., Mirza, M. & Coleman, R., 20 sep. 2019, I: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 27, s. 2449-2459 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  20. Udgivet
  21. Udgivet

    Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

    TRINOVA-3/ENGOT-ov2/GOG-3001 investigators, jun. 2019, I: Lancet Oncology. 20, 6, s. 862-876 15 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  22. Udgivet

    Combining conventional therapy with immunotherapy: A risky business?

    Coosemans, A., Vankerckhoven, A., Baert, T., Boon, L., Ruts, H., Riva, M., Blagden, S., Delforge, M., Concin, N., Mirza, M. R., Ledermann, J. A., du Bois, A. & Vergote, I., maj 2019, I: European journal of cancer (Oxford, England : 1990). 113, s. 41-44 4 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  23. Udgivet

    Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial

    Fabbro, M., Moore, K. N., Dørum, A., Tinker, A. V., Mahner, S., Bover, I., Banerjee, S., Tognon, G., Goffin, F., Shapira-Frommer, R., Wenham, R. M., Hellman, K., Provencher, D., Harter, P., Vázquez, I. P., Follana, P., Pineda, M. J., Mirza, M. R., Hazard, S. J. & Matulonis, U. A., mar. 2019, I: Gynecologic Oncology. 152, 3, s. 560-567 8 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  24. Udgivet

    Major clinical research advances in gynecologic cancer in 2018

    Kim, M., Suh, D. H., Lee, K. H., Eom, K. Y., Toftdahl, N. G., Mirza, M. R. & Kim, J. W., mar. 2019, I: Gynecologic Oncology. 30, 2, s. e18

    Publikation: Bidrag til tidsskriftReviewpeer review

  25. Udgivet
  26. Udgivet

    Chemotherapy in endometrial cancer

    Mirza, M. R., 2019, I: Springer Nature. s. 231-242

    Publikation: Bidrag til tidsskriftTidsskriftartikelFormidling

  27. Udgivet

    Management of endometrial cancer

    Mirza, M. R., 2019, I: Springer Nature.

    Publikation: Bidrag til tidsskriftTidsskriftartikelFormidling

  28. Udgivet

    Role of radiation therapy

    Mirza, M. R., 2019, I: Springer Nature. s. 223-229

    Publikation: Bidrag til tidsskriftTidsskriftartikelFormidling

  29. Udgivet

    Targetted therapy in management of Endometrial cancer Radiation

    Mirza, M. R., 2019, I: Springer Nature.

    Publikation: Bidrag til tidsskriftTidsskriftartikelFormidling

  30. Udgivet

    The need for level 1 evidence un daily practice

    Mirza, M. R., 2019, I: Springer Nature.

    Publikation: Bidrag til tidsskriftTidsskriftartikelFormidling

  31. 2018
  32. Udgivet

    Cancer of the corpus uteri

    Amant, F., Mirza, M. R., Koskas, M. & Creutzberg, C. L., okt. 2018, I: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 143 Suppl 2, s. 37-50 14 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  33. Udgivet

    Safety and dose modification for patients receiving niraparib

    Berek, J. S., Matulonis, U. A., Peen, U., Ghatage, P., Mahner, S., Redondo, A., Lesoin, A., Colombo, N., Vergote, I., Rosengarten, O., Ledermann, J., Pineda, M., Ellard, S., Sehouli, J., Gonzalez-Martin, A., Berton-Rigaud, D., Madry, R., Reinthaller, A., Hazard, S., Guo, W. & Mirza, M. R., 1 aug. 2018, I: Annals of Oncology. 29, 8, s. 1784-1792 9 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  34. Udgivet

    Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

    Oza, A. M., Matulonis, U. A., Malander, S., Hudgens, S., Sehouli, J., Del Campo, J. M., Berton-Rigaud, D., Banerjee, S., Scambia, G., Berek, J. S., Lund, B., Tinker, A. V., Hilpert, F., Vázquez, I. P., D'Hondt, V., Benigno, B., Provencher, D., Buscema, J., Agarwal, S. & Mirza, M. R., aug. 2018, I: Lancet Oncology. 19, 8, s. 1117-1125 9 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  35. Udgivet

    Latest clinical evidence and further development of PARP inhibitors in ovarian cancer

    Mirza, M. R., Pignata, S. & Ledermann, J. A., 1 jun. 2018, I: Annals of Oncology. 29, 6, s. 1366-1376 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  36. Udgivet

    The poly (ADP ribose) polymerase inhibitor niraparib: Management of toxicities

    Moore, K. N., Mirza, M. R. & Matulonis, U. A., apr. 2018, I: Gynecologic Oncology. 149, 1, s. 214-220 7 s.

    Publikation: Bidrag til tidsskriftReviewpeer review

  37. Udgivet

    Major clinical research advances in gynecologic cancer in 2017

    Suh, D. H., Kim, M., Lee, K. H., Eom, K. Y., Kjeldsen, M. K., Mirza, M. R. & Kim, J. W., mar. 2018, I: Gynecologic Oncology. 29, 2, s. e31

    Publikation: Bidrag til tidsskriftReviewpeer review

  38. 2017
  39. Udgivet

    Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial

    Bamias, A., Gibbs, E., Khoon Lee, C., Davies, L., Dimopoulos, M., Zagouri, F., Veillard, A-S., Kosse, J., Santaballa, A., Mirza, M. R., Tabaro, G., Vergote, I., Bloemendal, H., Lykka, M., Floquet, A., Gebski, V. & Pujade-Lauraine, E., 1 aug. 2017, I: Annals of Oncology. 28, 8, s. 1842-1848 7 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  40. Udgivet

    European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer

    Oonk, M. H. M., Planchamp, F., Baldwin, P., Bidzinski, M., Brännström, M., Landoni, F., Mahner, S., Mahantshetty, U., Mirza, M., Petersen, C., Querleu, D., Regauer, S., Rob, L., Rouzier, R., Ulrikh, E., van der Velden, J., Vergote, I., Woelber, L. & van der Zee, A. G. J., maj 2017, I: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 27, 4, s. 832-837 6 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  41. Udgivet

    Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease

    Wilson, M. K., Pujade-Lauraine, E., Aoki, D., Mirza, M. R., Lorusso, D., Oza, A. M., du Bois, A., Vergote, I., Reuss, A., Bacon, M., Friedlander, M., Gallardo-Rincon, D., Joly, F., Chang, S-J., Ferrero, A. M., Edmondson, R. J., Wimberger, P., Maenpaa, J., Gaffney, D., Zang, R., Okamoto, A., Stuart, G., Ochiai, K. & participants of the Fifth Ovarian Cancer Consensus Conference, 1 apr. 2017, I: Annals of Oncology. 28, 4, s. 727-732 6 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  42. Udgivet

    Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer

    Prahm, K. P., Høgdall, C., Karlsen, M. A., Christensen, I. J., Novotny, G. W., Knudsen, S., Hansen, A., Jensen, P. B., Jensen, T., Mirza, M. R., Ekmann-Gade, A. W., Nedergaard, L. & Høgdall, E., 23 mar. 2017, I: P L o S One. 12, 3, s. e0174300

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  43. Udgivet

    Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer

    Chen, Y., Camacho, S. C., Silvers, T. R., Razak, A. R. A., Gabrail, N. Y., Gerecitano, J. F., Kalir, E., Pereira, E., Evans, B. R., Ramus, S. J., Huang, F., Priedigkeit, N., Rodriguez, E., Donovan, M., Khan, F., Kalir, T., Sebra, R., Uzilov, A., Chen, R., Sinha, R., Halpert, R., Billaud, J-N., Shacham, S., McCauley, D., Landesman, Y., Rashal, T., Kauffman, M., Mirza, M. R., Mau-Sørensen, M., Dottino, P. & Martignetti, J. A., 15 mar. 2017, I: Clinical Cancer Research. 23, 6, s. 1552-1563 12 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  44. Udgivet

    Niraparib in Recurrent Ovarian Cancer

    Mirza, M. R. & Matulonis, U. A., 23 feb. 2017, I: The New England journal of medicine. 376, 8, s. 801-2 2 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  45. Udgivet

    ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer

    Marth, C., Vergote, I., Scambia, G., Oberaigner, W., Clamp, A., Berger, R., Kurzeder, C., Colombo, N., Vuylsteke, P., Lorusso, D., Hall, M., Renard, V., Pignata, S., Kristeleit, R., Altintas, S., Rustin, G., Wenham, R. M., Mirza, M. R., Fong, P. C., Oza, A., Monk, B. J., Ma, H., Vogl, F. D. & Bach, B. A., jan. 2017, I: European journal of cancer (Oxford, England : 1990). 70, s. 111-121 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  46. Udgivet
  47. 2016
  48. Udgivet

    First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors

    Abdul Razak, A. R., Mau-Soerensen, M., Gabrail, N. Y., Gerecitano, J. F., Shields, A. F., Unger, T. J., Saint-Martin, J. R., Carlson, R., Landesman, Y., McCauley, D., Rashal, T., Lassen, U., Kim, R., Stayner, L-A., Mirza, M. R., Kauffman, M., Shacham, S. & Mahipal, A., dec. 2016, I: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34, 34, s. 4142-4150 9 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  49. Udgivet

    Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study

    Pulford, D. J., Harter, P., Floquet, A., Barrett, C., Suh, D. H., Friedlander, M., Arranz, J. A., Hasegawa, K., Tada, H., Vuylsteke, P., Mirza, M. R., Donadello, N., Scambia, G., Johnson, T., Cox, C., Chan, J. K., Imhof, M., Herzog, T. J., Calvert, P., Wimberger, P., Berton-Rigaud, D., Lim, M. C., Elser, G., Xu, C-F. & du Bois, A., 21 okt. 2016, I: BMC Medical Ethics. 17, 1, s. e63

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  50. Udgivet

    Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

    Bois, A. D., Kristensen, G., Ray-Coquard, I., Reuss, A., Pignata, S., Colombo, N., Denison, U., Vergote, I., Del Campo, J. M., Ottevanger, P., Heubner, M., Minarik, T., Sevin, E., de Gregorio, N., Bidziński, M., Pfisterer, J., Malander, S., Hilpert, F., Mirza, M. R., Scambia, G., Meier, W., Nicoletto, M. O., Bjørge, L., Lortholary, A., Sailer, M. O., Merger, M., Harter, P. & AGO Study Group led Gynecologic Cancer Intergroup (GCIG)/European Network of Gynaecologic Oncology Trials Groups (ENGOT) Intergroup Consortium, jan. 2016, I: Lancet Oncology. 17, 1, s. 78–89

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  51. 2015
  52. Udgivet

    ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up

    Colombo, N., Creutzberg, C., Amant, F., Bosse, T., González-Martín, A., Ledermann, J., Marth, C., Nout, R., Querleu, D., Mirza, M. R., Sessa, C. & ESMO–ESGO–ESTRO Endometrial Consensus Conference Working Group, 9 dec. 2015, I: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 117, 3, s. 559-81

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  53. Udgivet

    Cancer of the corpus uteri

    Amant, F., Mirza, M. R., Koskas, M. & Creutzberg, C. L., okt. 2015, I: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 131 Suppl 2, s. S96-S104

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  54. Udgivet

    Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

    Oza, A. M., Cook, A. D., Pfisterer, J., Embleton, A., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., Park-Simon, T-W., Rustin, G., Joly, F., Mirza, M. R., Plante, M., Quinn, M., Poveda, A., Jayson, G. C., Stark, D., Swart, A. M., Farrelly, L., Kaplan, R., Parmar, M. K. B., Perren, T. J. & ICON7 trial investigators, aug. 2015, I: Lancet Oncology. 16, 8, s. 928-36 9 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  55. Udgivet

    Treatment of cervical cancer: recent achievements and future development

    Mirza, M. R., 2015, I: Cancer breaking news. 3, s. 6-13

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  56. 2014
  57. Udgivet

    A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

    Wang, Y., Herrstedt, J., Havsteen, H., DePoint Christensen, R., Mirza, M. R., Lund, B., Maenpaa, J. & Kristensen, G., 2014, I: B M C Cancer. 14, s. 937

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Forrige 1 2 Næste

ID: 28726